Ethris is a Germany-based biotechnology company that develops and commercializes mRNA-based therapeutics for the treatment of respiratory viral infections.
Business Model:
Revenue: $9.5M
Employees: 11-50
Address: Semmelweisstr. 3
City: Planegg
State: bavaria
Zip: 82152
Country: DE
Ethris is a Germany-based biotechnology company that develops and commercializes mRNA-based therapeutics for the treatment of respiratory viral infections.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2022 | Corporate Round | $16M |
Cipla (EU) Limited |
1/2022 | Series B | $26.3M |
Laureus Capital |
8/2017 | Corporate Round | 1 | $29.5M |
AstraZeneca AstraZeneca |
12/2022 | Corporate Round | 1 | $16M |
Cipla Cipla |
12/2011 | Series A | 2 | - |
HS LifeSciences OrbiMed HS LifeSciences OrbiMed |
2/2022 | Series B | $0 |
Laureus Capital Laureus Capital |
12/2021 | Grant | 1 | $18.6M |
Bavarian Ministry of Economics / Bayerisches Wirtschaftsministerium Bavarian Ministry of Economics / Bayerisches Wirtschaftsministerium |
7/2019 | Grant | - | 5/2011 | Grant | - | 2/2022 | Series B | 1 | $26.3M |
Laureus Capital Laureus Capital |
12/2021 | Grant | 1 | $18.6M |
Bavarian Ministry of Economics / Bayerisches Wirtschaftsministerium Bavarian Ministry of Economics / Bayerisches Wirtschaftsministerium |
7/2019 | Grant | - | 8/2017 | Corporate Round | 1 | $29.5M |
AstraZeneca AstraZeneca |
12/2011 | Series A | 1 | - |
HS LifeSciences HS LifeSciences |
5/2011 | Grant | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|